A Cho1, U Just1, R Knobler2. 1. Universitätsklinik für Dermatologie, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich. 2. Universitätsklinik für Dermatologie, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich. robert.knobler@meduniwien.ac.at.
Abstract
BACKGROUND: Graft-versus-host disease (GvHD) is a complex multiorgan disease, which can occur as a complication following allogeneic stem cell transplantation. Involvement of the skin represents the most common appearance of GvHD. The role of the dermatologist is critical for diagnosis and initiation of treatment. OBJECTIVES: The aim of this article is to provide a comprehensive review of the cutaneous types of GvHD and to present the most recent data on diverse therapy options for its acute and chronic form allowing the clinician to establish a definite diagnosis and to initiate proper therapy. MATERIALS AND METHODS: Possible clinical appearances and recommended criteria to assist in making the right diagnosis are presented by means of expert recommendations. RESULTS AND CONCLUSION: GvHD is still a complex entity whose diagnosis is often associated with challenges due to its variable presentation. Proper diagnosis and subsequent therapy is paramount for the optimal clinical outcome.
BACKGROUND:Graft-versus-host disease (GvHD) is a complex multiorgan disease, which can occur as a complication following allogeneic stem cell transplantation. Involvement of the skin represents the most common appearance of GvHD. The role of the dermatologist is critical for diagnosis and initiation of treatment. OBJECTIVES: The aim of this article is to provide a comprehensive review of the cutaneous types of GvHD and to present the most recent data on diverse therapy options for its acute and chronic form allowing the clinician to establish a definite diagnosis and to initiate proper therapy. MATERIALS AND METHODS: Possible clinical appearances and recommended criteria to assist in making the right diagnosis are presented by means of expert recommendations. RESULTS AND CONCLUSION:GvHD is still a complex entity whose diagnosis is often associated with challenges due to its variable presentation. Proper diagnosis and subsequent therapy is paramount for the optimal clinical outcome.
Authors: Fiona L Dignan; Andrew Clark; Persis Amrolia; Jacqueline Cornish; Graham Jackson; Prem Mahendra; Julia J Scarisbrick; Peter C Taylor; Nedim Hadzic; Bronwen E Shaw; Michael N Potter Journal: Br J Haematol Date: 2012-04-26 Impact factor: 6.998
Authors: Fiona L Dignan; Persis Amrolia; Andrew Clark; Jacqueline Cornish; Graham Jackson; Prem Mahendra; Julia J Scarisbrick; Peter C Taylor; Bronwen E Shaw; Michael N Potter Journal: Br J Haematol Date: 2012-04-26 Impact factor: 6.998
Authors: Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers Journal: Biol Blood Marrow Transplant Date: 2014-12-18 Impact factor: 5.742
Authors: Arvind R Murali; Subhash Chandra; Zoe Stewart; Bruce R Blazar; Umar Farooq; M Nedim Ince; Jeffrey Dunkelberg Journal: Transplantation Date: 2016-12 Impact factor: 4.939
Authors: Yoshihiro Inamoto; Barry E Storer; Effie W Petersdorf; J Lee Nelson; Stephanie J Lee; Paul A Carpenter; Brenda M Sandmaier; John A Hansen; Paul J Martin; Mary E D Flowers Journal: Blood Date: 2013-04-01 Impact factor: 22.113
Authors: Christine G DiRienzo; George F Murphy; Stephen C Jones; Robert Korngold; Thea M Friedman Journal: Biol Blood Marrow Transplant Date: 2006-08 Impact factor: 5.742
Authors: Peter Häusermann; Roland B Walter; Jörg Halter; Barbara C Biedermann; André Tichelli; Peter Itin; Alois Gratwohl Journal: Dermatology Date: 2008-01-29 Impact factor: 5.366